Andvari Associates, an investment management company, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here. For the full year of 2022, the fund was down 33.8% net of fees compared to the SPDR S&P 500 ETF, which was down 18.2%. In addition, please check the fund’s top five holdings to know its best picks in 2022.
Andvari Associates highlighted stocks like Mesa Laboratories, Inc. (NASDAQ:MLAB) in the fourth quarter 2022 investor letter. Headquartered in Lakewood, Colorado, Mesa Laboratories, Inc. (NASDAQ:MLAB) is a manufacturer and distributor of life sciences tools and quality control products and services. On January 31, 2023, Mesa Laboratories, Inc. (NASDAQ:MLAB) stock closed at $194.54 per share. One-month return of Mesa Laboratories, Inc. (NASDAQ:MLAB) was 9.07%, and its shares lost 30.41% of their value over the last 52 weeks. Mesa Laboratories, Inc. (NASDAQ:MLAB) has a market capitalization of $1.038 billion.
Andvari Associates made the following comment about Mesa Laboratories, Inc. (NASDAQ:MLAB) in its Q4 2022 investor letter:
“Mesa Laboratories, Inc. (NASDAQ:MLAB) sells equipment, instruments, and consumables for niche applications in the highly regulated life sciences, healthcare, and pharma markets. More than 60% of revenues are recurring or highly predictable. All its products provide high value relative to their cost. The company has high margins, robust cash flows, and minimal capex needs.
Furthermore, Mesa has vastly increased its potential since the hiring of CEO Gary Owens from Danaher. Danaher is a public company with an extraordinary business system of continuous improvement, problem solving, and listening to the customer, which enabled exemplary shareholder returns over the last 20 years. Gary has been created and implemented Mesa’s own business system—The Mesa Way— that has helped boost margins, increase growth, and increase customer satisfaction. The board has been upgraded with individuals with experience leading businesses with billions of revenues. Mesa is well positioned to continue growing as a serial acquirer of other high quality businesses.”
Tonhom1009/Shutterstock.com
Mesa Laboratories, Inc. (NASDAQ:MLAB) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 11 hedge fund portfolios held Mesa Laboratories, Inc. (NASDAQ:MLAB) at the end of the third quarter, which was 9 in the previous quarter.
We discussed Mesa Laboratories, Inc. (NASDAQ:MLAB) in another article and shared Conestoga Capital Advisors’ views on the company. In addition, please check out our hedge fund investor letters Q4 2022 page for more investor letters from hedge funds and other leading investors.
Suggested Articles:
- 12 Best Performing Cybersecurity Stocks
- 15 Most Undervalued Value Stocks To Buy
- 12 Cheap Energy Stocks To Buy
Disclosure: None. This article is originally published at Insider Monkey.
